Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

51.63
+0.35410.69%
Post-market: 51.640.0069+0.01%19:30 EDT
Volume:8K
Turnover:410.51K
Market Cap:175.04M
PE:- -
High:51.99
Open:51.57
Low:51.54
Close:51.28
52wk High:56.45
52wk Low:39.08
Shares:3.39M
Float Shares:3.39M
Volume Ratio:0.38
T/O Rate:0.23%
Dividend:0.00
Dividend Rate:0.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Krystal Biotech CEO Krish S. Krishnan Sells USD 7.59 Million in Common Shares

Reuters
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Mizuho survey shows no consensus into Alkermes ADHD data

TIPRANKS
·
Sep 05

Corcept Names Roberto Vieira as President, Oncology in Initial Beneficial Ownership Filing

Reuters
·
Sep 04

Alkermes EVP, CLO David Joseph Gaffin Disposes of 2,034 Common Shares Worth $97,651.34

Reuters
·
Sep 04

Krystal Biotech to Speak at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Sep 03

Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan

Dow Jones
·
Sep 03

Molina Healthcare Updates Financial Calendar with Third-Quarter Earnings Release, Conference Call

Reuters
·
Sep 02

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Reuters
·
Sep 02

Affordable Housing Stocks Investors Are Watching As Social Spending Moves Center Stage

Simply Wall St.
·
Sep 01

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move

TIPRANKS
·
Aug 29

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million

Reuters
·
Aug 28

Brightspring Health Services Inc Stock (BTSG) Closed Up by 7.20% on Aug 26: Key Drivers Unveiled

TradingKey
·
Aug 27

Roche receives FDA approval for companion diagnostic tests for Ziihera

TIPRANKS
·
Aug 27

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

TIPRANKS
·
Aug 27

Revolution Medicines announces FDA approval of Rasonque in adults

TIPRANKS
·
Aug 27

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25